[ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2017, Volume : 10, Issue : 9
First page : ( 3085) Last page : ( 3088)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2017.00547.9

A Prospective Observational Study on Microalbuminuria as Risk factor of Chronic Renal Failure in patients with Type 2 Diabetes

Sathyanarayanan G, Shanmugasundaram P.*, Geetha P.

Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University (VISTAS), Chennai, Tamilnadu, 600117

*Corresponding Author E-mail: samsimahe@gmail.com

Online published on 16 May, 2018.



Microalbuminuria was initially entrench predicator for renal failure and risk factor of cardiovascular diseases in type 2 diabetes mellitus patients as well as in general population. The main aim of the study was to determine the risk factor of chronic renal failure in type 2 diabetes mellitus patients using microalbumuria as a marker.


One hundred patients with type 2diabets mellitus patients, who are admitted in department of genral medicine in tertiary care hospital. The patients were evaluated patients age, detection of diabetes, sex, duration and clinical and biochemical observations: Blood pressure(BP), Blood sugar levels, serum creatinie (SrC), blood urea nitrogen (BUN) and microalbumuria.


In this study men population were found to be more percentage compared to female. The age group mean (50–70) patients was higher (22.5±8.26). Total no. of microalbuminuric in the study population was found to be 47.HbA1c were statistically significant. Duration of diabetic patients in microalbumuric patients is (15.6±8.621) Conclusion Microalbuminuria is an accurate predicator for Renal failure. Microalbumuria use of the screening test in those type 2 diabetes patients is to detect the early renal failure. Elderly patients with type 2 diabetes have the great risk of renal failure. It is possible to delay the progression of chronic renal failure by treatment of ACE inhibitors. In some research study suggest that early treatment with ACE inhibitors has proven to improve the renal progression



Microalbuminuria, hypertension, type2 diabetes.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
719,027,801 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.